Efficacy and safety of intragastric balloon for obesity in Korea
Background/Aims Intragastric balloon (IGB) is the only available endoscopic bariatric and metabolic therapy in Korea. End-ball (Endalis) has the longest history of clinical use among the IGBs available in Korea. However, little clinical data on this system have been reported. In this study, we aimed...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Society of Gastrointestinal Endoscopy
2023-05-01
|
| Series: | Clinical Endoscopy |
| Subjects: | |
| Online Access: | http://www.e-ce.org/upload/pdf/ce-2022-143.pdf |
| _version_ | 1797422444189843456 |
|---|---|
| author | Kwang Gyun Lee Seung-Joo Nam Hyuk Soon Choi Hang Lak Lee Jai Hoon Yoon Chan Hyuk Park Kyoung Oh Kim Do Hoon Kim Jung-Wook Kim Won Sohn Sung Hoon Jung |
| author_facet | Kwang Gyun Lee Seung-Joo Nam Hyuk Soon Choi Hang Lak Lee Jai Hoon Yoon Chan Hyuk Park Kyoung Oh Kim Do Hoon Kim Jung-Wook Kim Won Sohn Sung Hoon Jung |
| author_sort | Kwang Gyun Lee |
| collection | DOAJ |
| description | Background/Aims Intragastric balloon (IGB) is the only available endoscopic bariatric and metabolic therapy in Korea. End-ball (Endalis) has the longest history of clinical use among the IGBs available in Korea. However, little clinical data on this system have been reported. In this study, we aimed to evaluate the efficacy and safety of End-ball in Korea. Methods We performed a retrospective cohort study of patients who underwent IGB insertion (End-ball) from 2013 to 2019. Demographic and anthropometric data were collected. The efficacy and safety of IGB treatment were analyzed. Results In total, 80 patients were included. Mean age was 33.7 years and 83.8% were female. Initial body mass index was 34.48±4.69 kg/m2. Body mass index reduction was 3.72±2.63 kg/m2 at the time of IGB removal. Percent of total body weight loss (%TBWL) was 10.76%±6.76%. Percentage excess body weight loss was 43.67%±27.59%. Most adverse events were minor, and 71.4% of participants showed nausea, vomiting, or abdominal pain. Conclusions IGB treatment showed good efficacy and safety profile in Korean patients with obesity. In terms of %TBWL and percentage excess body weight loss, the efficacy was similar to that in the Western population. |
| first_indexed | 2024-03-09T07:32:23Z |
| format | Article |
| id | doaj.art-8c8be1951c254c95aa4052baad84d5bf |
| institution | Directory Open Access Journal |
| issn | 2234-2400 2234-2443 |
| language | English |
| last_indexed | 2024-03-09T07:32:23Z |
| publishDate | 2023-05-01 |
| publisher | Korean Society of Gastrointestinal Endoscopy |
| record_format | Article |
| series | Clinical Endoscopy |
| spelling | doaj.art-8c8be1951c254c95aa4052baad84d5bf2023-12-03T06:07:13ZengKorean Society of Gastrointestinal EndoscopyClinical Endoscopy2234-24002234-24432023-05-0156333333910.5946/ce.2022.1437693Efficacy and safety of intragastric balloon for obesity in KoreaKwang Gyun Lee0Seung-Joo Nam1Hyuk Soon Choi2Hang Lak Lee3Jai Hoon Yoon4Chan Hyuk Park5Kyoung Oh Kim6Do Hoon Kim7Jung-Wook Kim8Won Sohn9Sung Hoon Jung10 Department of Internal Medicine, We Comfortable Clinic, Seoul, Korea Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea Division of Gastroenterology, Department of Internal Medicine, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea Division of Gastroenterology, Department of Internal Medicine, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea Division of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaBackground/Aims Intragastric balloon (IGB) is the only available endoscopic bariatric and metabolic therapy in Korea. End-ball (Endalis) has the longest history of clinical use among the IGBs available in Korea. However, little clinical data on this system have been reported. In this study, we aimed to evaluate the efficacy and safety of End-ball in Korea. Methods We performed a retrospective cohort study of patients who underwent IGB insertion (End-ball) from 2013 to 2019. Demographic and anthropometric data were collected. The efficacy and safety of IGB treatment were analyzed. Results In total, 80 patients were included. Mean age was 33.7 years and 83.8% were female. Initial body mass index was 34.48±4.69 kg/m2. Body mass index reduction was 3.72±2.63 kg/m2 at the time of IGB removal. Percent of total body weight loss (%TBWL) was 10.76%±6.76%. Percentage excess body weight loss was 43.67%±27.59%. Most adverse events were minor, and 71.4% of participants showed nausea, vomiting, or abdominal pain. Conclusions IGB treatment showed good efficacy and safety profile in Korean patients with obesity. In terms of %TBWL and percentage excess body weight loss, the efficacy was similar to that in the Western population.http://www.e-ce.org/upload/pdf/ce-2022-143.pdfbariatricsgastric balloongastrointestinal endoscopesobesityweight reductions |
| spellingShingle | Kwang Gyun Lee Seung-Joo Nam Hyuk Soon Choi Hang Lak Lee Jai Hoon Yoon Chan Hyuk Park Kyoung Oh Kim Do Hoon Kim Jung-Wook Kim Won Sohn Sung Hoon Jung Efficacy and safety of intragastric balloon for obesity in Korea Clinical Endoscopy bariatrics gastric balloon gastrointestinal endoscopes obesity weight reductions |
| title | Efficacy and safety of intragastric balloon for obesity in Korea |
| title_full | Efficacy and safety of intragastric balloon for obesity in Korea |
| title_fullStr | Efficacy and safety of intragastric balloon for obesity in Korea |
| title_full_unstemmed | Efficacy and safety of intragastric balloon for obesity in Korea |
| title_short | Efficacy and safety of intragastric balloon for obesity in Korea |
| title_sort | efficacy and safety of intragastric balloon for obesity in korea |
| topic | bariatrics gastric balloon gastrointestinal endoscopes obesity weight reductions |
| url | http://www.e-ce.org/upload/pdf/ce-2022-143.pdf |
| work_keys_str_mv | AT kwanggyunlee efficacyandsafetyofintragastricballoonforobesityinkorea AT seungjoonam efficacyandsafetyofintragastricballoonforobesityinkorea AT hyuksoonchoi efficacyandsafetyofintragastricballoonforobesityinkorea AT hanglaklee efficacyandsafetyofintragastricballoonforobesityinkorea AT jaihoonyoon efficacyandsafetyofintragastricballoonforobesityinkorea AT chanhyukpark efficacyandsafetyofintragastricballoonforobesityinkorea AT kyoungohkim efficacyandsafetyofintragastricballoonforobesityinkorea AT dohoonkim efficacyandsafetyofintragastricballoonforobesityinkorea AT jungwookkim efficacyandsafetyofintragastricballoonforobesityinkorea AT wonsohn efficacyandsafetyofintragastricballoonforobesityinkorea AT sunghoonjung efficacyandsafetyofintragastricballoonforobesityinkorea |